Best of Breast: news for week ending 7 November 2014

News for Breast Cancer and Cancer, from Google Alerts, for the week ending 7 November 2014.

[Apologies, I’m so behind in Best of Breast it’s no joke. I’ve been sorting out personal issues the past months which have taken priority.  Looks as though I’ll be spending the festive season playing catch-up!]

One of the highlights this week is the proof that biphosphonates, used in breast cancer that has spread to the bones, can also prolong survival.  But before you all go out and get the family pack, please note that one of the possible side-effects of biphosphonates is osteonecrosis of the jaw (localised death of bone tissue).

There’s also more evidence to show that mindfulness meditation can affect the body at the cellular level.

fosamax

image credit: presstv.ir

 

1.  Biphosphonates can act on breast cancer tumours and prolong survival

Continue reading

Best of Breast: news for week ending 9 May 2014

News from Google Alerts, for Breast Cancer and Cancer, for the week ending 9 May 2014.

Lots 0f goodies this week, from the importance of sleep in survival rates to screening techniques, to more discoveries of genetic triggers for breast cancer.  But what stands out is news from Australia.  Graham Kelly, chief of Novogen, who is using a breakthrough cancer treatment for his own prostate cancer promises to deliver the drug at an affordable price.

One of the main criticisms of Big Pharma is how it overcharges for cancer drugs, leading to the accusation (and conspiracy theories) that all they want to do is exploit cancer patients who are desperate for a cure.  True, the path from discovery to trials to commercial release is expensive, but Graham Kelly of Novogen accuses Big Pharma of overpricing, and vows to do better with a fair price.  Whether this remains to be seen is debated, but it’s refreshing to see someone who’s in the business put his money where his mouth is, and to fess up to what critics of Big Pharma have been saying all along.  Good luck to him, is all I can say, long may he live and prosper.

Novogen

Superhero outfit optional. “We believe innovative medicine can be developed without the obscene price tags that make families mortgage their homes or strain federal health budgets” … Novogen boss Graham Kelly. Picture: Jim Trifyllis Source: News Corp Australia

1A.  Breakthrough cancer cell treatment from the University of NSW offers new hope

1B.  Novogen CEO Graham Kelly says he will make an anti-cancer drug at an affordable price

Continue reading

Supplement: metformin kills cancer stem cells

Metformin plant Galega Officinalis

Galega officinalis – source of Metformin
photo credit: wikipedia

If this post has helped you, please would you help me?  I am now fundraising for cancer treatments at GoFundMe http://www.gofundme.com/78jh2w or JustGiving:

https://www.justgiving.com/goBananasforRona

Updated 19 Jan 2014 with additional links to metformin and chemotherapy and radiotherapy, and dosage recommendations

Metformin is a drug that is usually used to control sugar level in people with Type 2 diabetes.

Tests have also shown that it may also be effective in reducing cancer risk, improving the survival of people with cancer, and inducing cancer cell death.

Metformin has been shown to selectively target and kill some lines of breast cancer stem cells.  As stem cells are usually resistant to chemotherapy, metformin is another tool you want to have in your kit.

It is speculated that metformin works by blocking a metabolic stress response that stimulates the inflammatory pathway associated with a wide variety of cancers. Continue reading